Cargando…
Process parameter development for the scaled generation of stem cell‐derived pancreatic endocrine cells
Diabetes is a debilitating disease characterized by high blood glucose levels. The global prevalence of this disease has been projected to reach 700 million adults by the year 2045. Type 1 diabetes represents about 10% of the reported cases of diabetes. Although islet transplantation can be a highly...
Autores principales: | Iworima, Diepiriye G., Rieck, Sebastian, Kieffer, Timothy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550703/ https://www.ncbi.nlm.nih.gov/pubmed/34387389 http://dx.doi.org/10.1002/sctm.21-0161 |
Ejemplares similares
-
Human Pluripotent Stem Cells to Model Islet Defects in Diabetes
por: Balboa, Diego, et al.
Publicado: (2021) -
Protocol development to further differentiate and transition stem cell-derived pancreatic progenitors from a monolayer into endocrine cells in suspension culture
por: Braam, Mitchell J. S., et al.
Publicado: (2023) -
Initial Cell Seeding Density Influences Pancreatic Endocrine Development During in vitro Differentiation of Human Embryonic Stem Cells
por: Gage, Blair K., et al.
Publicado: (2013) -
Convergent functional genomics of stem cell-derived cells
por: Niculescu, A B
Publicado: (2013) -
Prevention and treatment of cerebral palsy with cord blood stem cells and cord-derived mesenchymal stem cells
por: Shintaku, Haruo
Publicado: (2020)